Water-soluble stabilized self-assembled polyelectrolytes
View Patent ↗The present invention is directed toward water-soluble supramolecular self-assemblies and a process for their preparation via micellization of polyelectrolytes through the use of hydrophobic monomeric units. In this invention the polyelectrolyte segment ultimately forms the core of the supramolecular assembly whereas the shell consists of uncharged hydrophilic polymers or oligomers. It has been determined that the inclusion of the hydrophobic co-monomers to the polyelectrolyte segment forming the micelle core leads to a structure of enhanced stability.
1. A micelle having a hydrophobic core and a hydrophilic exterior for the delivery of a therapeutic agent, the micelle comprising:
a plurality of copolymers comprising at least one hydrophobic block and at least one hydrophilic block, wherein
(i) the hydrophobic block forms the hydrophobic core of the micelle and the hydrophilic block forms the hydrophilic exterior of the micelle;
(ii) the hydrophobic block comprises at least one ionizable and/or charged monomeric unit and at least one nonionic hydrophobic monomeric unit, wherein
the ionizable and/or charged monomeric unit comprises at least one moiety selected from the group consisting of an acrylic acid, an alkylacrylic acid, an (aminoalkyl) acrylate, and an (aminoalkyl)alkylacrylate, and
the non-ionic hydrophobic monomeric unit comprises at least one moiety selected from the group consisting of an acrylate, an acrylamide, an alkylacrylate, an alkylacrylamide, an arylacrylate, and an arylacrylamide; and
(iii) the hydrophilic block comprises a non-ionic hydrophilic polymer selected from the group consisting of polyethylene glycol and a polymer comprising vinyl monomeric units.
2. The micelle of claim 1 , wherein the ionizable and/or charged monomeric units comprise at least one alkylacrylic acid.
3. The micelle of claim 2 , wherein the alkylacrylic acid is methacrylic acid.
4. The micelle of claim 1 , wherein the nonionic hydrophobic monomeric unit comprises alkylacrylate.
5. The micelle of claim 4 , wherein the alkylacrylate is methacrylate.
6. The micelle of claim 5 , wherein the methacrylate is butylmethacrylate.
7. A micelle having a hydrophobic core and a hydrophilic exterior for the delivery of a therapeutic agent, the micelle comprising:
a plurality of copolymers comprising at least one hydrophobic block and at least one hydrophilic block, wherein
(i) the hydrophobic block forms the hydrophobic core of the micelle and the hydrophilic block forms the hydrophilic exterior of the micelle;
(ii) the hydrophobic block comprises an ionizable and/or charged monomeric unit comprising alkylacrylic acid and nonionic hydrophobic monomeric unit comprising alkylacrylate; and
(iii) the hydrophilic block comprises polyethylene glycol.
8. The micelle of claim 6 , wherein the alkylacrylic acid is methacrylic acid.
9. The micelle of claim 7 , wherein the alkylacrylate is methacrylate.
10. The micelle of claim 8 , wherein the alkylacrylate is methacrylate.
11. The micelle of claim 9 , wherein the methacrylate is butylmethacrylate.
12. The micelle of claim 10 , wherein the methacrylate is butylmethacrylate.
13. The micelle of claim 1 , wherein the micelle is pH-sensitive.
14. The micelle of claim 7 , wherein the micelle is pH-sensitive.
15. The composition of claim 1 , further comprising a therapeutic agent.
16. The composition of claim 2 , further comprising a therapeutic agent.
17. The composition of claim 3 , further comprising a therapeutic agent.
18. The composition of claim 7 , further comprising a therapeutic agent.
19. The composition of claim 8 , further comprising a therapeutic agent.
20. The composition of claim 15 , wherein the therapeutic agent is an antitumor compound.
21. The composition of claim 5 further comprising a therapeutic agent.
22. The composition of claim 21 , wherein the therapeutic agent is an antitumor compound.
23. The composition of claim 9 , further comprising a therapeutic agent.
24. The composition of claim 10 , further comprising a therapeutic agent.
25. The composition of claim 23 , wherein the therapeutic agent is an antitumor compound.